JP2018521959A5 - - Google Patents

Info

Publication number

JP2018521959A5

JP2018521959A5 JP2017556585A JP2017556585A JP2018521959A5 JP 2018521959 A5 JP2018521959 A5 JP 2018521959A5 JP 2017556585 A JP2017556585 A JP 2017556585A JP 2017556585 A JP2017556585 A JP 2017556585A JP 2018521959 A5 JP2018521959 A5 JP 2018521959A5

Authority

JP

Japan

Prior art keywords

antibody

btla

composition

item

binding

Prior art date

2016-04-29

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims description 37
• 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims description 37
• 238000000034 method Methods 0.000 claims description 30
• 239000003814 drug Substances 0.000 claims description 12
• 230000000694 effects Effects 0.000 claims description 12
• 229940079593 drug Drugs 0.000 claims description 9
• 229940122494 BTLA agonist Drugs 0.000 claims description 8
• 230000028993 immune response Effects 0.000 claims description 8
• 208000023275 Autoimmune disease Diseases 0.000 claims description 6
• 102000012220 Member 14 Tumor Necrosis Factor Receptors Human genes 0.000 claims description 6
• 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims description 6
• 239000003795 chemical substances by application Substances 0.000 claims description 6
• 208000027866 inflammatory disease Diseases 0.000 claims description 6
• 230000011664 signaling Effects 0.000 claims description 6
• 108010008165 Etanercept Proteins 0.000 claims description 4
• 101000998146 Homo sapiens Interleukin-17A Proteins 0.000 claims description 4
• 102100033461 Interleukin-17A Human genes 0.000 claims description 4
• 102000000704 Interleukin-7 Human genes 0.000 claims description 4
• 108010002586 Interleukin-7 Proteins 0.000 claims description 4
• 102000000585 Interleukin-9 Human genes 0.000 claims description 4
• 108010002335 Interleukin-9 Proteins 0.000 claims description 4
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 4
• 239000012634 fragment Substances 0.000 claims description 4
• 229960004641 rituximab Drugs 0.000 claims description 4
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 3
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 3
• 230000001363 autoimmune Effects 0.000 claims description 3
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
• 229940124597 therapeutic agent Drugs 0.000 claims description 3
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 2
• 208000026872 Addison Disease Diseases 0.000 claims description 2
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 2
• 208000023328 Basedow disease Diseases 0.000 claims description 2
• 102100032367 C-C motif chemokine 5 Human genes 0.000 claims description 2
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims description 2
• 108010065524 CD52 Antigen Proteins 0.000 claims description 2
• 102000013135 CD52 Antigen Human genes 0.000 claims description 2
• 108010012236 Chemokines Proteins 0.000 claims description 2
• 102000019034 Chemokines Human genes 0.000 claims description 2
• 208000011231 Crohn disease Diseases 0.000 claims description 2
• 208000014311 Cushing syndrome Diseases 0.000 claims description 2
• 102000004127 Cytokines Human genes 0.000 claims description 2
• 108090000695 Cytokines Proteins 0.000 claims description 2
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims description 2
• 102100023688 Eotaxin Human genes 0.000 claims description 2
• 108010072051 Glatiramer Acetate Proteins 0.000 claims description 2
• 208000009329 Graft vs Host Disease Diseases 0.000 claims description 2
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 2
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 claims description 2
• 208000015023 Graves' disease Diseases 0.000 claims description 2
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 2
• 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 claims description 2
• 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 claims description 2
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims description 2
• 101000978392 Homo sapiens Eotaxin Proteins 0.000 claims description 2
• 101001002634 Homo sapiens Interleukin-1 alpha Proteins 0.000 claims description 2
• 101001033279 Homo sapiens Interleukin-3 Proteins 0.000 claims description 2
• 101000617285 Homo sapiens Tyrosine-protein phosphatase non-receptor type 6 Proteins 0.000 claims description 2
• 102100026720 Interferon beta Human genes 0.000 claims description 2
• 108010005716 Interferon beta-1a Proteins 0.000 claims description 2
• 101710147309 Interferon epsilon Proteins 0.000 claims description 2
• 102100026688 Interferon epsilon Human genes 0.000 claims description 2
• 102100037850 Interferon gamma Human genes 0.000 claims description 2
• 108010047761 Interferon-alpha Proteins 0.000 claims description 2
• 102000006992 Interferon-alpha Human genes 0.000 claims description 2
• 108090000467 Interferon-beta Proteins 0.000 claims description 2
• 108010074328 Interferon-gamma Proteins 0.000 claims description 2
• 108010050904 Interferons Proteins 0.000 claims description 2
• 102000014150 Interferons Human genes 0.000 claims description 2
• 102100020881 Interleukin-1 alpha Human genes 0.000 claims description 2
• 102000003814 Interleukin-10 Human genes 0.000 claims description 2
• 108090000174 Interleukin-10 Proteins 0.000 claims description 2
• 102000003815 Interleukin-11 Human genes 0.000 claims description 2
• 108090000177 Interleukin-11 Proteins 0.000 claims description 2
• 102000013462 Interleukin-12 Human genes 0.000 claims description 2
• 108010065805 Interleukin-12 Proteins 0.000 claims description 2
• 102000003816 Interleukin-13 Human genes 0.000 claims description 2
• 108090000176 Interleukin-13 Proteins 0.000 claims description 2
• 102000003812 Interleukin-15 Human genes 0.000 claims description 2
• 108090000172 Interleukin-15 Proteins 0.000 claims description 2
• 102000000588 Interleukin-2 Human genes 0.000 claims description 2
• 108010002350 Interleukin-2 Proteins 0.000 claims description 2
• 102100039064 Interleukin-3 Human genes 0.000 claims description 2
• 102000004388 Interleukin-4 Human genes 0.000 claims description 2
• 108090000978 Interleukin-4 Proteins 0.000 claims description 2
• 102000000743 Interleukin-5 Human genes 0.000 claims description 2
• 108010002616 Interleukin-5 Proteins 0.000 claims description 2
• 102000015696 Interleukins Human genes 0.000 claims description 2
• 108010063738 Interleukins Proteins 0.000 claims description 2
• 206010028980 Neoplasm Diseases 0.000 claims description 2
• 201000004681 Psoriasis Diseases 0.000 claims description 2
• 201000001263 Psoriatic Arthritis Diseases 0.000 claims description 2
• 208000036824 Psoriatic arthropathy Diseases 0.000 claims description 2
• 206010039710 Scleroderma Diseases 0.000 claims description 2
• 241000966334 Simias Species 0.000 claims description 2
• 206010052779 Transplant rejections Diseases 0.000 claims description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 2
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 2
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 2
• 102100033019 Tyrosine-protein phosphatase non-receptor type 11 Human genes 0.000 claims description 2
• 101710116241 Tyrosine-protein phosphatase non-receptor type 11 Proteins 0.000 claims description 2
• 102100021657 Tyrosine-protein phosphatase non-receptor type 6 Human genes 0.000 claims description 2
• 206010047115 Vasculitis Diseases 0.000 claims description 2
• 229960003697 abatacept Drugs 0.000 claims description 2
• 229940119059 actemra Drugs 0.000 claims description 2
• 229960002964 adalimumab Drugs 0.000 claims description 2
• 239000000556 agonist Substances 0.000 claims description 2
• 229960000548 alemtuzumab Drugs 0.000 claims description 2
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 2
• 201000011510 cancer Diseases 0.000 claims description 2
• 229960003115 certolizumab pegol Drugs 0.000 claims description 2
• 208000025302 chronic primary adrenal insufficiency Diseases 0.000 claims description 2
• 229940038717 copaxone Drugs 0.000 claims description 2
• 230000001086 cytosolic effect Effects 0.000 claims description 2
• 239000003937 drug carrier Substances 0.000 claims description 2
• 150000002066 eicosanoids Chemical group 0.000 claims description 2
• 229940073621 enbrel Drugs 0.000 claims description 2
• 229960000403 etanercept Drugs 0.000 claims description 2
• 229960000556 fingolimod Drugs 0.000 claims description 2
• 229960001743 golimumab Drugs 0.000 claims description 2
• 208000024908 graft versus host disease Diseases 0.000 claims description 2
• 229940048921 humira Drugs 0.000 claims description 2
• 238000001727 in vivo Methods 0.000 claims description 2
• 229960000598 infliximab Drugs 0.000 claims description 2
• 229940047124 interferons Drugs 0.000 claims description 2
• 229940047122 interleukins Drugs 0.000 claims description 2
• 206010025135 lupus erythematosus Diseases 0.000 claims description 2
• ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 claims description 2
• 201000006417 multiple sclerosis Diseases 0.000 claims description 2
• OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 claims description 2
• 229960005027 natalizumab Drugs 0.000 claims description 2
• 229940094443 oxytocics prostaglandins Drugs 0.000 claims description 2
• 239000008194 pharmaceutical composition Substances 0.000 claims description 2
• 230000026731 phosphorylation Effects 0.000 claims description 2
• 238000006366 phosphorylation reaction Methods 0.000 claims description 2
• 201000009395 primary hyperaldosteronism Diseases 0.000 claims description 2
• 150000003180 prostaglandins Chemical class 0.000 claims description 2
• 229940038850 rebif Drugs 0.000 claims description 2
• 229940116176 remicade Drugs 0.000 claims description 2
• 206010039073 rheumatoid arthritis Diseases 0.000 claims description 2
• 201000000306 sarcoidosis Diseases 0.000 claims description 2
• 238000012216 screening Methods 0.000 claims description 2
• 229940068638 simponi Drugs 0.000 claims description 2
• 208000011580 syndromic disease Diseases 0.000 claims description 2
• 201000000596 systemic lupus erythematosus Diseases 0.000 claims description 2
• 229960000331 teriflunomide Drugs 0.000 claims description 2
• UTNUDOFZCWSZMS-YFHOEESVSA-N teriflunomide Chemical compound C\C(O)=C(/C#N)C(=O)NC1=CC=C(C(F)(F)F)C=C1 UTNUDOFZCWSZMS-YFHOEESVSA-N 0.000 claims description 2
• 229960003989 tocilizumab Drugs 0.000 claims description 2
• 239000000203 mixture Substances 0.000 claims 25
• SWZTYAVBMYWFGS-UHFFFAOYSA-N fingolimod hydrochloride Chemical compound Cl.CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1 SWZTYAVBMYWFGS-UHFFFAOYSA-N 0.000 claims 2
• 229940126585 therapeutic drug Drugs 0.000 claims 1
• 241001254135 Gillenia Species 0.000 description 1
• KKGQTZUTZRNORY-UHFFFAOYSA-N fingolimod Chemical compound CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1 KKGQTZUTZRNORY-UHFFFAOYSA-N 0.000 description 1